FREE Webinar: Ketamine, Psilocybin and New Drug Therapies

Watch the webinar HERE! For the last 10 years, Harris Bricken attorneys have counseled countless domestic and international businesses and entrepreneurs on rapidly evolving laws and regulations in the cannabis, hemp, and cannabidiol (CBD) industries. As the legal and regulatory frameworks of those industries begin to solidify, new opportunities are emerging for the commercialization and

Ketamine Clinics and Compliance Plans

In prior posts, we discussed some of the common due diligence and compliance issues for ketamine clinics (see here and here). In this post, we discuss a healthcare compliance plan and the importance of having one in place for ketamine clinics. The Department of Health and Human Services (“HHS”) (which houses, among other agencies, the

FREE Webinar on November 19th: Ketamine, Psilocybin and New Drug Therapies, Part 2!

Watch the webinar HERE! In case you missed the first webinar, you can WATCH IT HERE.   For the past decade, Harris Bricken attorneys have advised domestic and international businesses and entrepreneurs on rapidly evolving laws and regulations in the cannabis, hemp, and regulated substances industries. Over the last few years, our attorneys have led

FREE Webinar on November 19th: Ketamine, Psilocybin and New Drug Therapies, Part 2!

Watch the webinar HERE! In case you missed the first webinar, you can WATCH IT HERE.   For the past decade, Harris Bricken attorneys have advised domestic and international businesses and entrepreneurs on rapidly evolving laws and regulations in the cannabis, hemp, and regulated substances industries. Over the last few years, our attorneys have led

Ketamine Clinics and the DEA

Recently, we’ve been writing about ketamine-infusion clinics, which are increasingly popping up across the country (see a list of our past coverage at the end of this post). Over the coming weeks, we’ll dive deeper into individual laws and regulations governing clinics. Today, we focus on some of the high-level requirements of the Drug Enforcement

Ketamine, Psilocybin and New Drug Therapies: The Webinar Video Replay

Click HERE to learn more about the second part of this webinar!   On July 9th, California psychedelic attorneys Hilary Bricken (Los Angeles), Griffen Thorne (Los Angeles), Vince Sliwoski (Portland) and Jesse Mondry (Portland) hosted an interactive webinar to answer questions on the future of legalization and regulation of new drug therapies and alternative medicine, including: efforts to decriminalize and

Will Psilocybin Clinics Be The Next Big Thing in Treating Depression?

Earlier this year we wrote about the movement to decriminalize psilocybin – noting its success in Denver, Oakland, and Santa Cruz – and that nearly 100 other cities are looking at decriminalizing psychedelics. (The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not)). That article posited that psilocybin would move along two tracks

Is Kratom Legal?

Recently, our attorneys have seen a large uptick in interest, both from consumers and businesses, in ketamine and psychedelics. There has been a proliferation of ketamine clinics in the United States (see here here, and here), and dozens of jurisdictions (such as Denver and Oregon) passed or are considering passing psychedelics laws that would do